NCT05363657
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Recruiting · Not specified · Azienda Ospedaliero-Universitaria Careggi · registry updated 2022-05-06
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Partial nephrectomy (PN) is the standard treatment for localized renal masses and should be preferred in clinical T1 (\<7 cm tumor diameter) renal tumors over radical nephrectomy (RN) whenever technically feasible. Nonetheless, indications, approaches, techniques for PN, and correct reporting of outcomes, are still a matter of great debate within the urology community. Concurrently, case-report series suggested that alternative strategies for the treatment of localized renal tumors (ablation techniques (AT), watchful waiting (WW), active surveillance (AS)) could be feasible with acceptable oncologic outcomes in particular settings of patients with localized renal tumors. In this complex clinical scenario, the role surgeon-related and environmental factors (such as surgical experience, hospital resources, countries' social background and performance of health system) are important to address the best personalized approach in patients with renal tumors. In the light of current evidence, many unsolved questions still remain and many unmet needs must be addressed....
Inclusion
- Radiological diagnosis of renal tumor susceptible to active treatment or AS/WW.
- Age ≥18 years
- Informed consent signed
Exclusion
- Patient refuse to participate in clinical research.
- Urothelial renal carcinoma.